Scientists uncover two Crohn’s disease subtypes using lab-grown intestines, offering hope for personalized therapies

Researchers used stem-cell derived organoids from Crohn’s disease patients to identify two molecular subtypes, paving the way for personalized treatments targeting specific disease characteristics.

Horizon, Roche top list for pharma reputation among rare disease patient groups, survey finds

As rare disease drug research increases among large pharma companies, so do their reputations with rare disease patient groups. The latest survey in PatientView’s annual

August 23, 2023

Zimmer Biomet CEO Hanson departs for 3M

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Dive Insight: With leadership set

August 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Scientists uncover two Crohn’s disease subtypes using lab-grown intestines, offering hope for personalized therapies

Inflammatory profiles in vaccinated vs. unvaccinated individuals following SARS-CoV-2 infection

Horizon, Roche top list for pharma reputation among rare disease patient groups, survey finds

Zimmer Biomet CEO Hanson departs for 3M

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe